My Business Member Account
Business Member Portal
On this page, you can update your details, access training courses, and find other helpful resources to support your business membership of Anaphylaxis UK.
How are we doing?
Since our rebranding and new website in July 2022, we’ve already reached a staggering number of page views.
Our latest social media campaign reached over 650,000 unique people in 10 weeks with nearly 12,000 views on the campaign page and nearly 2,000 sign-ups to the campaign email.
Our Facebook page reaches 489,000 people and our organic post reach is over 72,500.
Our monthly newsletter has an open rate of over 56%.
Download
Download the Anaphylaxis UK Business Member logos along with the Brand Guidelines. Please use the Brand Guidelines on how to correctly display the logos and link to the Anaphylaxis Homepage: https://www.anaphylaxis.org.uk/
The Anaphylaxis UK Business Member logos
The Anaphylaxis UK Brand Guidelines
Exclusive training
Access training for you and colleagues here. The training courses are only available to Business Members.
Business News
Get the latest news. To feature news of your own, get in touch!
-
The emergency treatment of anaphylaxis in schools during the COVID-19 pandemic
Children are beginning to return to school under new social distancing rules and regulations. We have been contacted by concerned parents and school staff about how the COVID-19 epidemic and the restrictions in place because of it, affect the giving of emergency treatment to children experiencing a severe allergic reaction/anaphylaxis. Anaphylaxis is a potentially life-threatening…
-
Study reveals significant need, burden and psychosocial impact of peanut allergy
The largest European quantitative study on peanut allergy has highlighted varying levels of effective disease management between countries, as well as the associated feelings of uncertainty, stress and isolation experienced by those with peanut allergy and their caregivers. APPEAL-1 (Allergy to Peanuts imPacting Emotions And Life-1), a multi-dimensional pan-European study assessing the psychosocial effect and impact of…
-
MHRA issues important alert for Emerade 500mcg auto injectors
This is a recall for Emerade 500 microgram pens only. This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors and on 07 April 2020 for Emerade 300 microgram auto-injectors. Results from manufacturer testing of Emerade auto-injectors recalled from patients in Europe indicate that approximately 13% of pens…
Business Member services and products
Some of our Business Members are featured here.
-
Support an AllergyWise® School£300.00 inc. VAT
